| Dr Flora Holderbaum, AUD, CCC-A | |
|
3050 Corlear Ave, Suite 202, Bronx, NY 10463-5180 | |
| (212) 305-8555 | |
| (646) 317-5201 |
| Full Name | Dr Flora Holderbaum |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 19 Years |
| Location | 3050 Corlear Ave, Bronx, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659406908 | NPI | - | NPPES |
| 02474537 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 000732-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trustees Of Columbia University In The City Of New York | 8527972546 | 1895 |
News Archive
Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the power of biologics, today announced the initiation of a drug discovery collaboration with Genentech, a member of the Roche Group, to discover macrocyclic drug candidates against targets specified by Genentech.
"Speaking out against a potential $16 million cut in the Army's base research and development budget for HIV, leaders of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter Thursday to the Secretary of the U.S. Army, John McHugh, making the case for sustaining the U.S. Military HIV Research Program (MHRP)," according to the Center for Global Health Policy's "Science Speaks" blog.
Solos Endoscopy, Inc. is pleased to announce that the Company looks forward to a prosperous 2010, following a solid year in 2009, due in great part to its MammoView(TM) instrument line.
Regeneron Pharmaceuticals, Inc. announced that a Phase 3 study in gout patients initiating allopurinol therapy to lower their uric acid levels showed that ARCALYST (rilonacept), also known as IL-1 Trap, prevented gout attacks, as measured by the primary endpoint of the number of gout flares per patient over the 16 week treatment period.
› Verified 3 days ago
| Provider Name | Trustees Of Columbia University In The Department Of Otolaryngology |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1801074315 PECOS PAC ID: 5698853778 Enrollment ID: O20080416000002 |
News Archive
Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the power of biologics, today announced the initiation of a drug discovery collaboration with Genentech, a member of the Roche Group, to discover macrocyclic drug candidates against targets specified by Genentech.
"Speaking out against a potential $16 million cut in the Army's base research and development budget for HIV, leaders of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter Thursday to the Secretary of the U.S. Army, John McHugh, making the case for sustaining the U.S. Military HIV Research Program (MHRP)," according to the Center for Global Health Policy's "Science Speaks" blog.
Solos Endoscopy, Inc. is pleased to announce that the Company looks forward to a prosperous 2010, following a solid year in 2009, due in great part to its MammoView(TM) instrument line.
Regeneron Pharmaceuticals, Inc. announced that a Phase 3 study in gout patients initiating allopurinol therapy to lower their uric acid levels showed that ARCALYST (rilonacept), also known as IL-1 Trap, prevented gout attacks, as measured by the primary endpoint of the number of gout flares per patient over the 16 week treatment period.
› Verified 3 days ago
| Provider Name | Trustees Of Columbia University In The City Of New York |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508266347 PECOS PAC ID: 8527972546 Enrollment ID: O20151201002613 |
News Archive
Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the power of biologics, today announced the initiation of a drug discovery collaboration with Genentech, a member of the Roche Group, to discover macrocyclic drug candidates against targets specified by Genentech.
"Speaking out against a potential $16 million cut in the Army's base research and development budget for HIV, leaders of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter Thursday to the Secretary of the U.S. Army, John McHugh, making the case for sustaining the U.S. Military HIV Research Program (MHRP)," according to the Center for Global Health Policy's "Science Speaks" blog.
Solos Endoscopy, Inc. is pleased to announce that the Company looks forward to a prosperous 2010, following a solid year in 2009, due in great part to its MammoView(TM) instrument line.
Regeneron Pharmaceuticals, Inc. announced that a Phase 3 study in gout patients initiating allopurinol therapy to lower their uric acid levels showed that ARCALYST (rilonacept), also known as IL-1 Trap, prevented gout attacks, as measured by the primary endpoint of the number of gout flares per patient over the 16 week treatment period.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Flora Holderbaum, AUD, CCC-A 3050 Corlear Ave, Suite 202, Bronx, NY 10463-5180 Ph: (718) 543-4333 | Dr Flora Holderbaum, AUD, CCC-A 3050 Corlear Ave, Suite 202, Bronx, NY 10463-5180 Ph: (212) 305-8555 |
News Archive
Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the power of biologics, today announced the initiation of a drug discovery collaboration with Genentech, a member of the Roche Group, to discover macrocyclic drug candidates against targets specified by Genentech.
"Speaking out against a potential $16 million cut in the Army's base research and development budget for HIV, leaders of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter Thursday to the Secretary of the U.S. Army, John McHugh, making the case for sustaining the U.S. Military HIV Research Program (MHRP)," according to the Center for Global Health Policy's "Science Speaks" blog.
Solos Endoscopy, Inc. is pleased to announce that the Company looks forward to a prosperous 2010, following a solid year in 2009, due in great part to its MammoView(TM) instrument line.
Regeneron Pharmaceuticals, Inc. announced that a Phase 3 study in gout patients initiating allopurinol therapy to lower their uric acid levels showed that ARCALYST (rilonacept), also known as IL-1 Trap, prevented gout attacks, as measured by the primary endpoint of the number of gout flares per patient over the 16 week treatment period.
› Verified 3 days ago
Alla Avdashchenko, MA, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Pelham Pkwy S, Building 1, Room 5n1, Bronx, NY 10461 Phone: 718-918-6275 | |
Tricia Anne Raymond, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1200 Waters Pl Ste 110, Bronx, NY 10461 Phone: 718-863-4366 | |
Mrs. Evmorfia Tzanis, MA, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 130 W Kingsbridge Rd, Bronx, NY 10468 Phone: 718-584-9000 | |
Dr. Brenda Lilia Guerrero, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-518-5864 | |
Dr. Carmen Santiago, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-518-5659 | |
Pelham Audiology Assoc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1934 Williamsbridge Rd, Bronx, NY 10461 Phone: 718-822-4100 | |
Nikol Leitner, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3400 Bainbridge Ave. Map 3rd Floor, Montefiore Medical Center, Dept Of Otorhinolaryngology, Bronx, NY 10467 Phone: 718-920-4250 Fax: 718-920-8112 |